OIG Tells FDA to Make Cybersecurity Concerns a Criterion for RTF
In a detailed report of the current practices for application review by FDA, the Office of Inspector General (OIG), Department of Health and Human Services, recommended FDA take additional steps to assure that medical devices are protected from cybersecurity issues. These include having sponsors discuss cybersecurity issues at pre-submission meetings, adding cybersecurity assessment in the … Read more